<DOC>
	<DOC>NCT03039686</DOC>
	<brief_summary>This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of BMS-986089 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
	<criteria>Diagnosed with DMD by a blood test Able to walk without assistance Able to walk up 4 stairs in 8 seconds or less Weigh at least 15 kg (33 lbs) Taking corticosteroids for DMD Any behavior or mental issue that will affect the ability to complete the required study procedures Previously or currently taking medications like androgens or human growth hormone Use of a ventilator during the day Unable to have blood samples collected or receive an injection under the skin Other protocol defined Inclusion/Exclusion Criteria could apply.</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>muscular dystrophy</keyword>
	<keyword>Duchenne's Muscular Dystrophy</keyword>
	<keyword>DMD</keyword>
</DOC>